Krempa David bought ETON

May 27, 2026 · Form 4 insider transaction

Krempa David bought 12,476 shares of Eton Pharmaceuticals, Inc. at $1.37 per share, a transaction worth $17.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
12,476
Price
$1.37
Total value
$17.1K
Role
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 27, 2026
Filing dateMay 27, 2026
Shares owned after37,725
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR